Literature DB >> 23327524

Application of metabolomics to diagnosis of insulin resistance.

Michael V Milburn1, Kay A Lawton.   

Abstract

Metabolomics, the global interrogation of the biochemical components in a biological sample, has become an important complement to genomics and proteomics to aid in the understanding of pathophysiology. Major advantages of metabolomics are the size of the metabolome relative to the genome or proteome and the fact that it provides a view of the existing biochemical phenotype. As such, metabolomics is fast becoming an important discovery tool for new diagnostic and prognostic biomarkers. Although many methods exist for performing metabolomics, relatively few have led to successful development of new diagnostic tests. This review will aid the reader in understanding various metabolomic methods and their applications, as well as some of their inherent advantages and disadvantages. In addition, we present one example of the application of metabolomics to the identification of new fasting blood biomarkers for the diagnosis and monitoring of insulin resistance.

Entities:  

Mesh:

Year:  2013        PMID: 23327524     DOI: 10.1146/annurev-med-061511-134747

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  22 in total

1.  Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.

Authors:  Lining Guo; Michael V Milburn; John A Ryals; Shaun C Lonergan; Matthew W Mitchell; Jacob E Wulff; Danny C Alexander; Anne M Evans; Brandi Bridgewater; Luke Miller; Manuel L Gonzalez-Garay; C Thomas Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

2.  A novel fasting blood test for insulin resistance and prediabetes.

Authors:  Jeff Cobb; Walter Gall; Klaus-Peter Adam; Pamela Nakhle; Eric Button; James Hathorn; Kay Lawton; Michael Milburn; Regis Perichon; Matthew Mitchell; Andrea Natali; Ele Ferrannini
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

Review 3.  Everything is autoimmune until proven otherwise.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 4.  Knockout mouse models of insulin signaling: Relevance past and future.

Authors:  Anne E Bunner; P Charukeshi Chandrasekera; Neal D Barnard
Journal:  World J Diabetes       Date:  2014-04-15

5.  Laboratory Determined Sugar Content and Composition of Commercial Infant Formulas, Baby Foods and Common Grocery Items Targeted to Children.

Authors:  Ryan W Walker; Michael I Goran
Journal:  Nutrients       Date:  2015-07-16       Impact factor: 5.717

6.  The complex role of branched chain amino acids in diabetes and cancer.

Authors:  Thomas M O'Connell
Journal:  Metabolites       Date:  2013-10-14

7.  An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery.

Authors:  Sophie H Narath; Selma I Mautner; Eva Svehlikova; Bernd Schultes; Thomas R Pieber; Frank M Sinner; Edgar Gander; Gunnar Libiseller; Michael G Schimek; Harald Sourij; Christoph Magnes
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

8.  Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium.

Authors:  Takashi Shiroto; Natalia Romero; Toru Sugiyama; Juliano L Sartoretto; Hermann Kalwa; Zhonghua Yan; Hiroaki Shimokawa; Thomas Michel
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 9.  Using Metabolomic Profiles as Biomarkers for Insulin Resistance in Childhood Obesity: A Systematic Review.

Authors:  Xue Zhao; Xiaokun Gang; Yujia Liu; Chenglin Sun; Qing Han; Guixia Wang
Journal:  J Diabetes Res       Date:  2016-07-19       Impact factor: 4.011

10.  LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.

Authors:  Ruijuan Chen; Yi Zeng; Wenbiao Xiao; Le Zhang; Yi Shu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-30       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.